-$0.12 Earnings Per Share Expected for Exscientia Ltd (NASDAQ:EXAI) This Quarter

Analysts expect Exscientia Ltd (NASDAQ:EXAI) to post earnings per share of ($0.12) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Exscientia’s earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.19). The company is expected to announce its next earnings report on Wednesday, February 16th.

According to Zacks, analysts expect that Exscientia will report full-year earnings of ($0.50) per share for the current financial year, with EPS estimates ranging from ($0.63) to ($0.37). For the next fiscal year, analysts anticipate that the company will report earnings of ($0.58) per share, with EPS estimates ranging from ($0.60) to ($0.56). Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that cover Exscientia.

Exscientia (NASDAQ:EXAI) last posted its earnings results on Wednesday, November 17th. The company reported ($0.08) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.21) by $0.13. The firm had revenue of $24.33 million for the quarter.

EXAI has been the subject of a number of analyst reports. Morgan Stanley initiated coverage on Exscientia in a research note on Tuesday, October 26th. They issued an “equal weight” rating and a $25.00 price target for the company. Bank of America initiated coverage on Exscientia in a research note on Tuesday, October 26th. They issued a “buy” rating and a $27.00 price target for the company. The Goldman Sachs Group initiated coverage on Exscientia in a research note on Tuesday, October 26th. They issued a “buy” rating and a $30.00 price target for the company. Finally, Zacks Investment Research raised Exscientia from a “hold” rating to a “buy” rating and set a $22.00 price target for the company in a research note on Wednesday, December 29th.

EXAI opened at $18.80 on Wednesday. Exscientia has a fifty-two week low of $17.02 and a fifty-two week high of $30.38. The company has a debt-to-equity ratio of 0.02, a current ratio of 4.80 and a quick ratio of 4.80. The stock’s fifty day moving average price is $20.17.

About Exscientia

Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.

See Also: What is a SEC Filing?

Get a free copy of the Zacks research report on Exscientia (EXAI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exscientia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exscientia and related companies with MarketBeat.com's FREE daily email newsletter.